| Authors: |
Rosen M; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. mr1832@rwjms.rutgers.edu.; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. mr1832@rwjms.rutgers.edu., Fontil V; Department of Population Health and Institute of Excellence in Health Equity, NYU Grossman School of Medicine, New York, NY, USA., Faulkner Modrow M; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Smith SM; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA., Carton TW; Louisiana Public Health Institute, New Orleans, LA, USA., Chamberlain AM; Department of Quantitative Health Sciences, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., O'Brien EC; Duke Clinical Research Institute and Duke University School of Medicine, Durham, NC, USA., Park S; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Orozco J; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Cooper DeHoff RM; Department of Pharmacotherapy and Translational Research, College of Pharmacy and Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Wozniak G; American Medical Association, Chicago, IL, USA., Rakotz M; American Medical Association, Chicago, IL, USA., McCulloch CE; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Pletcher MJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA. |